| Date Filed | Type | Description |
| 07/10/2023 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 17.3% stake in Adaptimmune Therapeutics PLC |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/03/2022 |
SC 13D
| Matrix Capital Management Company, LP reports a 16.4% stake in Zentalis Pharmaceuticals, Inc. |
| 02/18/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 16.9% stake in Altair Engineering, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 9.6% stake in Zentalis Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G
| Matrix Capital Management Company, LP reports a 7.7% stake in Perimeter Solutions, SA |
| 02/14/2022 |
SC 13G
| Matrix Capital Management Company, LP reports a 7.9% stake in ForgeRock, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 0% stake in BigCommerce Holdings, Inc. |
| 11/04/2021 |
SC 13D
| Matrix Capital Management Company, LP reports a 14.5% stake in Aura Biosciences, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G
| Matrix Capital Management Company, LP reports a 9.4% stake in Zentalis Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G
| Matrix Capital Management Company, LP reports a 5.3% stake in BigCommerce Holdings, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 11.9% stake in Altair Engineering, Inc. |
| 02/14/2020 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 5.9% stake in CarGurus, Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| Matrix Capital Management Company, LP reports a 13.9% stake in Adaptive Biotechnologies Corporation |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 0% stake in Trillium Therapeutics Inc. |
| 02/14/2019 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 15.6% stake in Trillium Therapeutics Inc. |
| 02/14/2019 |
SC 13G
| Matrix Capital Management Company, LP reports a 5.4% stake in CarGurus, Inc. |
| 02/14/2019 |
SC 13G
| Matrix Capital Management Company, LP reports a 5.4% stake in Tableau Software, Inc. |
| 01/10/2019 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 26% stake in Adaptimmune Therapeutics PLC |
| 10/10/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 0.8% stake in Pandora Media, Inc. |
|